Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Renal Cell 10Kidney Neoplasms 5Neoplasms 4Gastrointestinal Stromal Tumors 4Breast Neoplasms 2Thyroid Neoplasms 1Somatostatinoma 1Solid Tumors 1Refractory Solid Tumors 1Neoplasm Metastasis 1Glioma 1Gastrointestinal Neoplasms 1Fatigue 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Adenoma, Islet Cell 1

Interventions

Magnetic Resonance Spectroscopy 16Blood Specimen Collection 8Temozolomide 5Magnetic Resonance Imaging 5Bevacizumab 4Yoga 3Radiotherapy, Intensity-Modulated 3Biopsy 3Transcranial Magnetic Stimulation 2Surveys and Questionnaires 2Restraint, Physical 2Radiosurgery 2Radiation 2Psychosocial Intervention 2Proton Therapy 2Physical Therapy Modalities 2Palliative Care 2Mind-Body Therapies 2Mental Status and Dementia Tests 2Heart Rate 2Gadolinium DTPA 2Exercise 2Elasticity Imaging Techniques 2Drug Therapy 2Diffusion Tensor Imaging 2Congresses as Topic 2Aminolevulinic Acid 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vandetanib 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Glioma × Sunitinib × Clear all
NCT02239952 2020-10-08

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

Amsterdam UMC, location VUmc

Phase NA Unknown
15 enrolled
CNS

Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡